PubMed

Immunohistochemical evaluation of human epidermal growth factor receptor 2 and estrogen and progesterone receptors in breast carcinoma in Jordan.

Almasri NM, Al Hamad M.

Breast Cancer Res. 2005;7(5):R598-604. Epub 2005 May 24.PMID: 16168103 [PubMed - indexed for MEDLINE]Related articlesFree article

Correlation of HER-2 over-expression with clinico-pathological parameters in Tunisian breast carcinoma.

Ayadi L, Khabir A, Amouri H, Karray S, Dammak A, Guermazi M, Boudawara T.

World J Surg Oncol. 2008 Oct 22;6:112.PMID: 18945339 [PubMed - indexed for MEDLINE]Related articlesFree article

Comparison of ER, PR and HER-2/neu (C-erb B 2) reactivity pattern with histologic grade, tumor size and lymph node status in breast cancer.

Azizun-Nisa, Bhurgri Y, Raza F, Kayani N.

Asian Pac J Cancer Prev. 2008 Oct-Dec;9(4):553-6.PMID: 19256737 [PubMed - indexed for MEDLINE]Related articles

Morphological profile and association of HER-2/neu with prognostic markers in breast carcinoma in Northern Pakistan.

Sharif MA, Mamoon N, Mushtaq S, Khadim MT.

J Coll Physicians Surg Pak. 2009 Feb;19(2):99-103.PMID: 19208313 [PubMed - indexed for MEDLINE]Related articles

Correlation of her-2/neu gene amplification with other prognostic and predictive factors in female breast carcinoma.

Ariga R, Zarif A, Korasick J, Reddy V, Siziopikou K, Gattuso P.

Breast J. 2005 Jul-Aug;11(4):278-80.PMID: 15982396 [PubMed - indexed for MEDLINE]Related articles

Human epidermal growth factor receptor 2 status correlates with lymph node involvement in patients with estrogen receptor (ER) negative, but with grade in those with ER-positive early-stage breast cancer suitable for cytotoxic chemotherapy.

Bartlett JM, Ellis IO, Dowsett M, Mallon EA, Cameron DA, Johnston S, Hall E, A'Hern R, Peckitt C, Bliss JM, Johnson L, Barrett-Lee P, Ellis P.

J Clin Oncol. 2007 Oct 1;25(28):4423-30.PMID: 17906205 [PubMed - indexed for MEDLINE]Related articles

Immunohistochemical analysis of ER, PR, HER-2, CK 5/6, p63 and EGFR antigen expression in medullary breast cancer.

Matkovic B, Juretic A, Separovic V, Novosel I, Separovic R, Gamulin M, Kruslin B.

Tumori. 2008 Nov-Dec;94(6):838-44.PMID: 19267102 [PubMed - indexed for MEDLINE]Related articles

Remarkably high frequency of EGFR expression in breast carcinomas with squamous differentiation.

Bossuyt V, Fadare O, Martel M, Ocal IT, Burtness B, Moinfar F, Leibl S, Tavassoli FA.

Int J Surg Pathol. 2005 Oct;13(4):319-27.PMID: 16273187 [PubMed - indexed for MEDLINE]Related articles

Routine assessment of hormonal receptor and her-2/neu status underscores the need for more therapeutic targets in Kenyan women with breast cancer.

Nyagol J, Nyong'o A, Byakika B, Muchiri L, Cocco M, de Santi MM, Spina D, Bellan C, Lazzi S, Kostopoulos I, Luzi P, Leoncini L.

Anal Quant Cytol Histol. 2006 Apr;28(2):97-103.PMID: 16637512 [PubMed - indexed for MEDLINE]Related articles

[Expression of estrogen receptor, progesterone receptor, and human epithelial growth factor receptor 2 in breast cancer and the significance thereof: analysis of 910 cases]

Liu RB, Zhou XH, Wang JN, Liang HZ, Li XX, Wu ZH, Ye JL, Wang SM.

Zhonghua Yi Xue Za Zhi. 2008 Dec 30;88(48):3397-400. Chinese. PMID: 19159568 [PubMed - indexed for MEDLINE]Related articles

Association between tumour characteristics and HER-2/neu by immunohistochemistry in 1362 women with primary operable breast cancer.

Huang HJ, Neven P, Drijkoningen M, Paridaens R, Wildiers H, Van Limbergen E, Berteloot P, Amant F, Vergote I, Christiaens MR.

J Clin Pathol. 2005 Jun;58(6):611-6.PMID: 15917412 [PubMed - indexed for MEDLINE]Related articlesFree article

Frequency of HER-2/neu receptor positivity and its association with other features of breast cancer.

Naeem M, Nasir A, Aman Z, Ahmad T, Samad A.

J Ayub Med Coll Abbottabad. 2008 Jul-Sep;20(3):23-6.PMID: 19610508 [PubMed - indexed for MEDLINE]Related articles

Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positive.

Van Calster B, Vanden Bempt I, Drijkoningen M, Pochet N, Cheng J, Van Huffel S, Hendrickx W, Decock J, Huang HJ, Leunen K, Amant F, Berteloot P, Paridaens R, Wildiers H, Van Limbergen E, Weltens C, Timmerman D, Van Gorp T, Smeets A, Van den Bogaert W, Vergote I, Christiaens MR, Neven P.

Breast Cancer Res Treat. 2009 Jan;113(1):181-7. Epub 2008 Feb 9.PMID: 18264760 [PubMed - indexed for MEDLINE]Related articles

Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance.

Arpino G, Weiss H, Lee AV, Schiff R, De Placido S, Osborne CK, Elledge RM.

J Natl Cancer Inst. 2005 Sep 7;97(17):1254-61.PMID: 16145046 [PubMed - indexed for MEDLINE]Related articlesFree article

Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer.

Konecny G, Pauletti G, Pegram M, Untch M, Dandekar S, Aguilar Z, Wilson C, Rong HM, Bauerfeind I, Felber M, Wang HJ, Beryt M, Seshadri R, Hepp H, Slamon DJ.

J Natl Cancer Inst. 2003 Jan 15;95(2):142-53.PMID: 12529347 [PubMed - indexed for MEDLINE]Related articlesFree article

Histological and immuno-histochemical study of male breast carcinoma in Northern Pakistan.

Sharif MA, Mamoon N, Arif A, Mushtaq S, Khadim MT.

J Pak Med Assoc. 2009 Feb;59(2):67-71.PMID: 19260565 [PubMed - indexed for MEDLINE]Related articles

Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.

Basu S, Chen W, Tchou J, Mavi A, Cermik T, Czerniecki B, Schnall M, Alavi A.

Cancer. 2008 Mar 1;112(5):995-1000.PMID: 18098228 [PubMed - indexed for MEDLINE]Related articlesFree article

Prognostic variables in invasive breast cancer: contribution of comedo versus noncomedo in situ component.

Brower ST, Ahmed S, Tartter PI, Bleiweiss I, Amberson JB.

Ann Surg Oncol. 1995 Sep;2(5):440-4.PMID: 7496840 [PubMed - indexed for MEDLINE]Related articles

Tissue microarray-based studies of patients with lymph node negative breast carcinoma show that met expression is associated with worse outcome but is not correlated with epidermal growth factor family receptors.

Tolgay Ocal I, Dolled-Filhart M, D'Aquila TG, Camp RL, Rimm DL.

Cancer. 2003 Apr 15;97(8):1841-8.PMID: 12673709 [PubMed - indexed for MEDLINE]Related articlesFree article

Differential amplification and overexpression of HER-2/neu, p53, MIB1, and estrogen receptor/progesterone receptor among medullary carcinoma, atypical medullary carcinoma, and high-grade invasive ductal carcinoma of breast.

Xu R, Feiner H, Li P, Yee H, Inghirami G, Delgado Y, Perle MA.

Arch Pathol Lab Med. 2003 Nov;127(11):1458-64.PMID: 14567723 [PubMed - indexed for MEDLINE]Related articles